Showing results (41-50 of 131) with videos related to
Sort By:
Pageof 14
Radiology|December 18, 2019
Deep Learning for Predicting Enhancing Lesions in Multiple Sclerosis from Noncontrast MRIPonnada A Narayana, Ivan Coronado, Sheeba J Sujit, et al.Neurology|August 11, 2021
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease SpectrumMarcus W Koch, Jop Mostert, Yinan Zhang, et al.Annals of Biomedical Engineering|March 10, 2006
Unified approach for multiple sclerosis lesion segmentation on brain MRIBalasrinivasa Rao Sajja, Sushmita Datta, Renjie He, et al.Journal of Magnetic Resonance Imaging : JMRI|April 30, 2016
Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosisRefaat E Gabr, Khader M Hasan, Muhammad E Haque, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosisFlavia Nelson, Sushmita Datta, Nereyda Garcia, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2016
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary noteGuoqiao Wang, Gary R Cutter, Stacey S Cofield, et al.Radiology|January 16, 2008
Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: initial findingsAziz H Poonawalla, Khader M Hasan, Rakesh K Gupta, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 18, 2011
Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosisKhader M Hasan, Indika S Walimuni, Humaira Abid, et al.Multiple Sclerosis and Related Disorders|July 22, 2015
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40 mg three-times weekly versus 20 mg daily in patients with relapsing-remitting multiple sclerosisJerry S Wolinsky, T Erik Borresen, Dennis W Dietrich, et al.European Journal of Neurology|December 20, 2021
Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosisMarcus W Koch, Jop Mostert, Pavle Repovic, et al.Pageof 14